Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients.

NGS-defined targeted therapy PDXs chemotherapy combination squamous NSCLC

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
07 Aug 2024
Historique:
received: 09 07 2024
revised: 30 07 2024
accepted: 05 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

The combination of chemotherapy and targeted therapy has been validated in non-small-cell lung cancer (NSCLC) patients with

Identifiants

DOI: 10.3390/cancers16162785 PMID: 39199558
pubmed: 39199558
pii: cancers16162785
doi: 10.3390/cancers16162785
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Didier Decaudin (D)

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.
Department of Medical Oncology, Institut Curie, 75005 Paris, France.

Fariba Némati (F)

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.
ORCID: 0000-0001-8879-7592

Julien Masliah Planchon (J)

Department of Genetic, Institut Curie, 75005 Paris, France.
ORCID: 0000-0002-5596-3926

Agathe Seguin-Givelet (A)

Department of Thoracic Surgery, Curie-Montsouris Thorax Institute, Institut Mutualiste Montsouris, 75014 Paris, France.
Faculty of Medicine SMBH, Paris 13 University, Sorbonne Paris Cité, 75013 Bobigny, France.
ORCID: 0000-0002-2906-4433

Marine Lefevre (M)

Department of Pathology, Institut Mutualiste Montsouris, 75014 Paris, France.
ORCID: 0000-0003-2216-1481

Vesnie Etienne (V)

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.

Harry Ahnine (H)

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.

Quentin Peretti (Q)

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.

Laura Sourd (L)

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.

Rania El-Botty (R)

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.

Lea Huguet (L)

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.

Sarah Lagha (S)

Department of Medical Oncology, Institut Curie, 75005 Paris, France.
ORCID: 0009-0001-2085-7787

Nadia Hegarat (N)

Department of Medical Oncology, Institut Curie, 75005 Paris, France.
ORCID: 0009-0008-7612-8381

Sergio Roman-Roman (S)

Department of Translationnal Research, Institut Curie, PSL University Paris, 75006 Paris, France.

Ivan Bièche (I)

Department of Genetic, Institut Curie, 75005 Paris, France.

Nicolas Girard (N)

Department of Medical Oncology, Institut Curie, 75005 Paris, France.
Paris Saclay University, University of Versailles Saint-Quentin-en-Yvelines (UVSQ), 91405 Versailles, France.

Elodie Montaudon (E)

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, 75005 Paris, France.
ORCID: 0009-0002-5197-8300

Classifications MeSH